UNITY Biotechnology Reports Granting of New Employment …
2 days ago · SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing …
UNITY Biotechnology Announces Appointment of Federico …
3 days ago · SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, …
UNITY Biotechnology Announces Appointment of Federico …
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse …
Unity Biotechnology Names Federico Grossi Chief Medical …
3 days ago · (RTTNews) - Shares of Unity Biotechnology, Inc. (UBX) are gaining 9% in the pre-market trading after it has announced the appointment of Federico Grossi as Chief Medical …
Unity Biotechnology, Inc. (UBX) Latest Stock News & Headlines
Get the latest Unity Biotechnology, Inc. (UBX) stock news and headlines to help you in your trading and investing decisions.
Unity Biotechnology Inc. - MarketWatch
Jan 3, 2025 · UBX | Complete Unity Biotechnology Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
UNITY Biotechnology Reports Granting of New Employment
2 days ago · SOUTH SAN FRANCISCO, Calif., Jan. 07, 2025 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing …
UNITY Biotechnology Announces Results from Phase 2 …
Mar 27, 2023 · UNITY is developing a new class of therapeutics to slow, halt, or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate …
UNITY Biotech Appoints SYFOVRE Developer Dr. Grossi as CMO …
3 days ago · UNITY Biotechnology strengthens leadership with Federico Grossi, former Apellis CMO who led SYFOVRE approval, as company approaches Phase 2b ASPIRE trial readout …
Release Details - Unity Biotechnology
Apr 15, 2024 · UNITY is developing a new class of therapeutics to slow, halt, or reverse diseases of aging. UNITY’s current focus is on creating medicines to selectively eliminate or modulate …